D
ata and AI are revolutionizing musculoskeletal healthcare by providing real-time insights into patient recovery and treatment effectiveness. This shift is reminiscent of the impact of electrocardiograms on heart medicine over a century ago, which transformed from cumbersome machines that required multiple operators to portable devices now ubiquitous in hospitals.

    In musculoskeletal care, objective measures of joint motion and muscle function were previously only accessible in elite performance labs at great cost and time commitment. FIGUR8's bioMotion Assessment Platform (bMAP) has made this technology available at any point of care for injured individuals, offering a user-friendly and easily interpretable platform.

    FIGUR8 is pioneering the use of biomotion sensing technology to enhance musculoskeletal healthcare through data-driven insights. CEO Dr. Nan-Wei Gong emphasizes that the future of musculoskeletal care lies in personalized, data-driven approaches, enabled by technology's ability to collect and analyze large datasets quickly.

    The company's platform tracks patients' recovery from injury to health by measuring movement at different stages, providing a clear visualization of the recovery trajectory and enabling feedback during the process. This granularity of data allows for comprehensive understanding of an injury's impact on the body, including joint angles and overall ability to function within a healthy range.

    FIGUR8's technology is being used in partnerships with clinicians across nearly every state, resulting in successful outcomes and reduced recovery times compared to standard timelines. The company's mission extends beyond offering a product to driving change in musculoskeletal care through collaboration among government, insurance companies, providers, and patients.

    By harnessing the power of data and AI, FIGUR8 is redefining the way musculoskeletal health is measured, delivering improved clinical and financial outcomes for patients, providers, and payers.